Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05776147
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-03-08
Brief Title:
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil a Retrospective Cohort Study
Sponsor:
Latin American Cooperative Oncology Group
Organization:
Latin American Cooperative Oncology Group
Study Overview
Official Title:
Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil a Retrospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RADIANT
Brief Summary:
The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and therefore it is necessary to analyze the Brazilian national experience in selected patients with breast cancer with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol
Detailed Description:
All patients diagnosed with breast cancer who meet the eligibility criteria at participating centers will be included Data will be collected from medical records at selected centers Data collection will start from the location activation date Data from up to 500 patients are expected to be collected at centers across Brazil
Patients recruited for this study will be identified at participating centers Data on clinical demographic and socioeconomic variables will be collected as well as data on treatments performed and outcomes
The patient data sources will be the patients medical records Patients will continue to receive treatment and clinical evaluations for their illness as determined by their medical team in accordance with the standards of care and usual clinical practice at each center No intervention is proposed in this study
Patients recruited for this study will be identified at participating centers Data on clinical demographic and socioeconomic variables will be collected as well as data on treatments performed and outcomes
The patient data sources will be the patients medical records Patients will continue to receive treatment and clinical evaluations for their illness as determined by their medical team in accordance with the standards of care and usual clinical practice at each center No intervention is proposed in this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None